Experimental | Number of studies | ART study size (n) | SC study size (n) | OR; 95% CI | I2 (%) | P value | NNH (n) |
---|---|---|---|---|---|---|---|
Hypertensive Disorders of Pregnancy | |||||||
 IVF/ICSI singleton | 51 | 268,166 | 7,728,641 | 1.70 (1.60–1.80) | 80 | < 0.01a | 47.2 |
 IVF singleton | 5 | 41,238 | 437,723 | 1.55 (1.23–1.94) | 90 | < 0.01a | 85.9 |
 ICSI singleton | 9 | 27,108 | 446,149 | 1.52 (1.28–1.80) | 75 | < 0.01a | 54.3 |
 IVF/ICSI multiple | 41 | 88,853 | 120,396 | 1.34 (1.20–1.50) | 76 | < 0.01a | 47.8 |
 IVF multiple | 4 | 13,147 | 73,297 | 1.13 (0.98–1.29) | 59 | 0.09 | 86.3 |
 ICSI multiple | 10 | 9924 | 77,179 | 1.11 (0.91–1.36) | 77 | 0.30 | 12.8 |
 Fresh embryo transfer singleton | 16 | 162,867 | 4,381,981 | 1.43 (1.33–1.53) | 72 | < 0.01a | 57.4 |
 Frozen embryo transfer singleton | 9 | 41,462 | 4,090,152 | 1.74 (1.58–1.92) | 55 | < 0.01a | 52.6 |
 Oocyte donation singleton | 9 | 12,461 | 2,413,466 | 4.42 (3.00–6.51) | 83 | < 0.01a | 16.3 |
 Oocyte donation multiple | 2 | 10,488 | 59,045 | 2.62 (2.46–2.79) | 0 | < 0.01a | 10.2 |
Preeclampsia | Â | ||||||
 IVF/ICSI singleton | 28 | 118,787 | 4,509,905 | 1.59 (1.46–1.74) | 70 | < 0.01a | 81.0 |
 ICSI singleton | 2 | 5807 | 31,124 | 0.98 (0.38–2.51) | 72 | 0.97 | 105.2 |
 IVF/ICSI multiple | 17 | 14,842 | 34,337 | 1.24 (1.08–1.43) | 32 | < 0.01a | 91.7 |
 IVF multiple | 2 | 5696 | 25,998 | 1.04 (0.93–1.16) | 0 | 0.47 | 364.0 |
 ICSI multiple | 5 | 5618 | 29,519 | 1.11 (1.00–1.24) | 0 | 0.05a | 52.1 |
 Fresh embryo transfer singleton | 8 | 55,300 | 2,715,647 | 1.48 (1.37–1.60) | 39 | < 0.01a | 85.5 |
 Frozen embryo transfer singleton | 5 | 19,216 | 2,699,693 | 1.82 (1.71–1.95) | 0 | < 0.01a | 45.6 |
 Oocyte donation singleton | 7 | 1107 | 1,031,110 | 5.20 (4.02–6.73) | 9 | < 0.01a | 10.1 |